In a filing, ICU Medical, Inc. revealed its VP, GM-Infusion Capital Woolson Daniel unloaded Company’s shares for reported $77733.0 on Mar 15 ’24. In the deal valued at $98.27 per share,791 shares were sold. As a result of this transaction, Woolson Daniel now holds 13,980 shares worth roughly $1.42 million.
Then, LOPEZ GEORGE A sold 7,978 shares, generating $812,741 in total proceeds. Upon selling the shares at $101.87, the Director now owns 877,343 shares.
Before that, LOPEZ GEORGE A sold 1,522 shares. ICU Medical, Inc. shares valued at $154,497 were divested by the Director at a price of $101.51 per share. As a result of the transaction, LOPEZ GEORGE A now holds 316,231 shares, worth roughly $32.18 million.
Raymond James downgraded its ICU Medical, Inc. [ICUI] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including CJS Securities’s analysts, who increased its forecast for the stock in late March from “a Market perform” to “a Market outperform”. KeyBanc Capital Markets also remained covering ICUI and has increased its forecast on March 18, 2020 with a “an Overweight” recommendation from previously “Sector weight” rating. Raymond James revised its rating on August 08, 2019. It rated ICUI as “an Outperform” which previously was an “a Strong buy”.
Price Performance Review of ICUI
On Tuesday, ICU Medical, Inc. [NASDAQ:ICUI] saw its stock jump 1.05% to $101.77. Over the last five days, the stock has gained 3.93%. ICU Medical, Inc. shares have risen nearly 2.04% since the year began. Nevertheless, the stocks have fallen -44.89% over the past one year. While a 52-week high of $212.43 was reached on 02/28/24, a 52-week low of $78.28 was recorded on 02/05/24. SMA at 50 days reached $100.78, while 200 days put it at $109.23. A total of 0.36 million shares were traded, compared to the trading of 0.3 million shares in the previous session.
Levels Of Support And Resistance For ICUI Stock
The 24-hour chart illustrates a support level at 100.53, which if violated will result in even more drops to 99.28. On the upside, there is a resistance level at 103.04. A further resistance level may holdings at 104.30. The Relative Strength Index (RSI) on the 14-day chart is 58.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.11, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.29%. Stochastics %K at 83.79% indicates the stock is a selling.
The most recent change occurred on October 17, 2017 when KeyBanc Capital Mkts began covering the stock and recommended ‘”a Sector weight”‘ rating.
